AnteoTech (ASX:ADO) YoY EPS Growth: 29.41% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AnteoTech YoY EPS Growth?

AnteoTech ASX:ADO -5.56% YoY EPS Growth is 29.41% as of Jun. 2026. The stock has 5 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. AnteoTech's YoY EPS Growth for the quarter that ended in Jun. 2026 was 29.41%.

AnteoTech's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was A$-0.00.

AnteoTech YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for AnteoTech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnteoTech YoY EPS Growth Chart

AnteoTech Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -58.82 -16.67 38.10 33.33 34.62

AnteoTech Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.78 27.27 39.29 37.50 29.41

AnteoTech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

AnteoTech's YoY EPS Growth for the fiscal year that ended in Jun. 2026 is calculated as:

YoY EPS Growth (A: Jun. 2026 )
=(Earnings per Share (Diluted) (A: Jun. 2026 )-Earnings per Share (Diluted) (A: Jun. 2025 ))/ | Earnings per Share (Diluted) (A: Jun. 2025 ) |
=(-0.0017--0.0026)/ | -0.0026 |
=34.62 %

AnteoTech's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(-0.0012--0.0017)/ | -0.0017 |
=29.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 29.41% mean?
AnteoTech (ASX:ADO) has a YoY EPS Growth of 29.41% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for AnteoTech and its competitors.
Is AnteoTech's YoY EPS Growth too high?
AnteoTech's current YoY EPS Growth is 29.41%.
How does AnteoTech's YoY EPS Growth compare to LIN and SHW?
AnteoTech's YoY EPS Growth of 29.41% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Chemicals company?
A good YoY EPS Growth depends on the Chemicals industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for AnteoTech and its competitors. AnteoTech's current YoY EPS Growth is 29.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AnteoTech stock overvalued right now?
AnteoTech (ASX:ADO) has a current YoY EPS Growth of 29.41%. The current YoY EPS Growth is 29.41%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For AnteoTech (ASX:ADO), the current YoY EPS Growth is 29.41% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AnteoTech Business Description

Address 4/26 Brandl Street, Eight Mile Plains, Brisbane, QLD, AUS, 4113
AnteoTech Ltd is an Australian biotechnology and materials company that develops surface-coating and binder technologies for energy and life-science applications. Its core proprietary technology, AnteoBind, is used to attach biomolecules and particles to surfaces, supporting products such as AnteoBind NXT and AnteoX, which serve diagnostics, medical device, and battery markets. In energy, the company develops binder and electrode additive technologies, including Ultranode, aimed at improving lithium-ion battery performance for battery manufacturers. Its life-science business supplies reagents and components to diagnostic test developers and medical device makers. AnteoTech operates primarily from Australia, generates revenue through product sales, licensing, collaborative development agreements, and grant-funded research, and serves customers in the diagnostics, medical device, and battery materials industries internationally.